MedTrace Logo

Glycoprotein Matrix-Bound Iron Improves Iron Absorption

NCT06738199 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2024-12-17

No results posted yet for this study

Summary

A double-blind, randomized crossover study was conducted that evaluated absorption kinetics of 3 forms of dietary supplement iron by measuring iron levels in the blood after acute ingestion.

Conditions

  • Evaluation of Bioavailability of Supplemental Forms of Iron

Interventions

DIETARY_SUPPLEMENT

dietary iron supplementation

This study aimed to compare the absorption kinetics of iron bound to a glycoprotein matrix (GPM) with those of ferrous bisglycinate chelate (FBC) and ferrous fumarate (FF).

Sponsors & Collaborators

  • Pharmachem Innovations

    collaborator UNKNOWN

  • University of Mary Hardin-Baylor

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-02-01
Primary Completion
2024-04-22
Completion
2024-04-22

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06738199 on ClinicalTrials.gov